Finally, Zandberg and Strome (2014) described the role of PD-L1 and PD-1 in head and neck squamous cell carcinoma, and carefully considered how their activities can be manipulated as a therapeutic strategy. The gene discussed is RPL17; the disease is head and neck squamous cell carcinoma.